News

City of San Antonio enacting plan to better leverage military medical assets

  The San Antonio Military Life Science Commercialization Action Plan seeks to better leverage ...

Rapamycin Holdings Treats First Humans in eRapa Clinical Trial

Featured image is of SwRI staff working in their cGMP clean room where clinical supplies of their ...

Events

Learn to Prepare IND for Small Molecule Drugs

How does a drug development program evolve from a brilliant research idea? Join Southwest Research Institute ...
News
Texas Biomed to pursue new strategy targeting infectious disease
June 21, 2018

Dr. Larry Schlesinger is president and CEO of Texas Biomedical Research Institute. JOSH HUSKIN

By W. Scott Bailey – Senior Reporter, San Antonio Business Journal

Texas Biomedical Research Institute’s board has approved a 10-year master plan for the West San Antonio campus.

The new strategic plan will include a less-is-more approach with an eye on enabling Texas Biomed to focus more on core competencies. One area that’s been identified as a main target of opportunity is infectious disease. CEO Dr. Larry Schlesinger said the board approved a plan to “create a one-of-a-kind infectious disease research institute unrivaled in its expertise, resources and programming.”

Texas Biomed officials have warned that the institute faces several challenges that threaten its survival, and Schlesinger has called for transformative change to better position the institute for long-term success.

The unanimous vote clears the path for implementing a new game plan for the institute nearly a year in the making.

Stakeholders said the plan will help bring together the best minds and provide the resources needed to advance the study of how people are impacted by infection. The changes are expected to lead to improvement in diagnosing, preventing and curing such diseases.

“The plan is bold but transformational. Life-saving discoveries are only made with the implementation of ambitious ideas, and we are ready to get started,” Schlesinger said.

Schlesinger told me in February, during an exclusive interview, that he had called on outside expertise to help reimagine the West San Antonio campus. That group, Teconomy Partners LLC, a technology-centric economic development consulting company, is based in Ohio, the state he called home before taking the CEO job at Texas Biomed.

“Part of our strategic planning process is to have a north star for the institute to define ourselves — not only internally, but also externally,” he said.

The new strategic plan will help leadership identify and secure the talent and the brick-and-mortar infrastructure needed to better position Texas Biomed — and San Antonio— as a global epicenter for new discovery combating infectious disease.

Stay informed. Subscribe to BioMed SA news alerts.